CRISPR Gene Editing Leads to Improvements
CRISPR gene editing leads to improvements in vision for people with inherited blindness, clinical trial shows.
Search results
CRISPR gene editing leads to improvements in vision for people with inherited blindness, clinical trial shows.
This time we are joined by Roly Megaw, Clinical Lecturer and Honorary Consultant Ophthalmologist at University of Edinburgh and NHS Lothian
Our partnerships are mutually beneficial. For Retina UK this means we can fund more research and offer support on a local level, while our partners can achieve corporate social responsibility objectives whilst making a tangible impact.
Our Keynote speaker will be Mr Kanmin Xue. Mr Xue is a Consultant Vitreo-retinal Surgeon at the John Radcliffe Hospital and Wellcome Trust clinician scientist fellow at the University of Oxford where he leads the Retinal Disease and Repair Group.
Do you want to win up to £25,000 and feel good about supporting people with inherited progressive sight loss?!
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Friday 23 May, 5.30pm - 9.30pm - In-person - Come and join Bhavini and the group for their latest outing to see an audio described performance of The Play That Goes Wrong at the Duchess Theatre in London.
Genetic testing, usually via a blood sample, is used to try and identify which gene contains the fault that is causing an individual’s sight loss.
Elena Piotter, a PhD student working in Robert MacLaren’s group in the Nuffield Laboratory of Ophthalmology at the University of Oxford, is currently researching DNA and RNA base editing tools aiming to correct pathogenic mutations in ABCA4.
The latest webinar from Retina UK.